Ventas Inc. diskutieren
Ventas (NYSE:VTR) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $93.00 price target on the stock.
Ratings data for VTR provided by MarketBeat
Ventas (NYSE:VTR) had its price target raised by analysts at KeyCorp from $85.00 to $90.00. They now have an "overweight" rating on the stock.
Ratings data for VTR provided by MarketBeat
Ventas (NYSE:VTR) was given a new $91.00 price target on by analysts at Royal Bank Of Canada. They now have an "outperform" rating on the stock.
Ratings data for VTR provided by MarketBeat
Ventas (VTR) had its price target raised by Mizuho from $87.00 to $94.00. They now have an "outperform" rating on the stock.
Ratings data for VTR provided by MarketBeat
Neueste Beiträge
JPMorgan_Chase___Co_ in Acadia Pharmaceuticals diskutieren